Filing Details

Accession Number:
0001232583-17-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-17 18:17:16
Reporting Period:
2017-02-15
Filing Date:
2017-02-17
Accepted Time:
2017-02-17 18:17:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628908 Evolent Health Inc. EVH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232583 Steve Wigginton C/O Evolent Health, Inc.
800 N. Glebe Road, Suite 500
Arlington VA 22203
Ceo, Valence Health No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2017-02-15 12,000 $3.84 371,692 No 4 M Direct
Class A Common Stock Disposition 2017-02-15 6,000 $20.12 365,692 No 4 S Direct
Class A Common Stock Disposition 2017-02-15 6,000 $20.13 359,692 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class A Common Stock (right to buy) Disposition 2017-02-15 12,000 $0.00 12,000 $3.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
435,680 2024-04-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016.
  2. The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.00-$20.25, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.00-$20.25, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014.